Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Respiratory Safety of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.

NCT04746105 is registered in ClinicalTrials.gov with Taisho Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT04746105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04746105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Respiratory Safety of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.
Lead sponsor
Taisho Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
February 24, 2021
Completion date
October 30, 2021
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with mild obstructive sleep apnea hypopnea